SOUTH SAN FRANCISCO and SUNNYVALE, Calif.-– Fluidigm Corp. (NASDAQ: FLDM) today announced it has completed its acquisition of DVS Sciences, Inc. With the closing of the acquisition, Fluidigm adds a high-parameter single-cell protein analysis platform to its industry-leading single-cell genomics platforms to create a comprehensive portfolio of advanced technologies serving the rapidly growing single-cell genomics […]

Cambridge, UK –Horizon Discovery™ (Horizon), a leading provider of research tools to support translational genomics and the development of personalized medicines, today announced it has signed a worldwide distribution agreement with Haplogen GmbH (Haplogen), with immediate effect. Under the terms of the agreement customers can now access, directly from Horizon, Haplogen’s Haploid Gene Trap Mutant […]

Golden, Colorado——Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced that its revenues increased substantially (78%, unaudited) in its first 2014 fiscal quarter due to its growing and expanding business relationship with Neuromics, Inc. Vitro has now commercialized bio-analytical services as the initial stage in its expansion as a Contract Research Organization (CRO). The services […]

Franklin Lakes, NJ -– BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global technology company, today announced the appointment of Amit Bhalla as Vice President, Global Strategy and Development. Mr. Bhalla will join BD in March, 2014 and will report to Vincent A. Forlenza, Chairman, Chief Executive Officer and President. “I am pleased to welcome […]

SHEFFIELD, UK,2014: Phase Focus Ltd (Phasefocus), the company that is revolutionising microscopy and imaging with the Phasefocus Virtual Lens®, announces the availability of the Virtual Lens series of label-free live cell imaging systems. Phase Focus Ltd (Phasefocus) announces a family of innovative phase microscopy systems for live cell imaging using the Phasefocus Virtual Lens®. The […]

WALTHAM, Mass.–Thermo Fisher Scientific (NYSE: TMO), the world leader in serving science, today announced that it has completed its acquisition of Life Technologies Corporation (NASDAQ: LIFE) for $76.13 ($76.1311786) in cash per fully diluted common share, or approximately $13.6 billion, plus the assumption of $1.5 billion in net debt. The completion of the transaction follows […]

Thermo Fisher Scientific Inc. (Thermo Fisher), a leading manufacturer of products used in scientific research, has agreed to sell assets to GE Healthcare to settle Federal Trade Commission charges that its proposed $13.6 billion acquisition of Life Technologies Corporation (Life) would likely substantially lessen competition. The FTC complaint challenging the transaction alleges that the deal, […]

Brussels,The European Commission has approved today General Electric as the purchaser of Thermo Fisher’s divestments businesses producing and supplying (i) media and sera for cell culture, (ii) gene silencing products, and (iii) polymer-based magnetic beads. Thermo Fisher had committed to divest these three businesses as a condition for the Commission to allow the acquisition of […]

Cambridge, UK – Horizon Discovery™ (Horizon), a leading provider of research tools to support translational genomics and the development of personalized medicines, today announced it has entered into a large-scale licensing agreement with a Japanese medical university. The agreement covers a limited use label license for academic use of 250 of Horizon’s X-MAN™ genetically defined, […]